Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $6.48 billion. The enterprise value is $9.33 billion.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 60.51 million shares outstanding. The number of shares has decreased by -5.26% in one year.
| Current Share Class | 60.51M |
| Shares Outstanding | 60.51M |
| Shares Change (YoY) | -5.26% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 3.10% |
| Owned by Institutions (%) | 100.73% |
| Float | 58.58M |
Valuation Ratios
The trailing PE ratio is 14.25 and the forward PE ratio is 13.56. JAZZ's PEG ratio is 1.21.
| PE Ratio | 14.25 |
| Forward PE | 13.56 |
| PS Ratio | 1.62 |
| Forward PS | 1.47 |
| PB Ratio | 1.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.28 |
| P/OCF Ratio | 4.16 |
| PEG Ratio | 1.21 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 6.16.
| EV / Earnings | 19.34 |
| EV / Sales | 2.29 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 12.77 |
| EV / FCF | 6.16 |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 1.30.
| Current Ratio | 3.38 |
| Quick Ratio | 2.64 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 3.81 |
| Debt / FCF | 3.58 |
| Interest Coverage | 2.20 |
Financial Efficiency
Return on equity (ROE) is 12.25% and return on invested capital (ROIC) is 4.79%.
| Return on Equity (ROE) | 12.25% |
| Return on Assets (ROA) | 3.99% |
| Return on Invested Capital (ROIC) | 4.79% |
| Return on Capital Employed (ROCE) | 7.08% |
| Revenue Per Employee | $1.45M |
| Profits Per Employee | $172,213 |
| Employee Count | 2,800 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 0.60 |
Taxes
| Income Tax | -120.91M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.19% in the last 52 weeks. The beta is 0.33, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -5.19% |
| 50-Day Moving Average | 107.89 |
| 200-Day Moving Average | 118.29 |
| Relative Strength Index (RSI) | 44.35 |
| Average Volume (20 Days) | 793,900 |
Short Selling Information
The latest short interest is 5.71 million, so 9.44% of the outstanding shares have been sold short.
| Short Interest | 5.71M |
| Short Previous Month | 5.95M |
| Short % of Shares Out | 9.44% |
| Short % of Float | 9.75% |
| Short Ratio (days to cover) | 4.27 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.06 billion and earned $482.20 million in profits. Earnings per share was $7.51.
| Revenue | 4.06B |
| Gross Profit | 3.75B |
| Operating Income | 730.48M |
| Pretax Income | n/a |
| Net Income | 482.20M |
| EBITDA | 1.39B |
| EBIT | 730.48M |
| Earnings Per Share (EPS) | $7.51 |
Full Income StatementBalance Sheet
The company has $2.57 billion in cash and $5.42 billion in debt, giving a net cash position of -$2.85 billion or -$47.06 per share.
| Cash & Cash Equivalents | 2.57B |
| Total Debt | 5.42B |
| Net Cash | -2.85B |
| Net Cash Per Share | -$47.06 |
| Equity (Book Value) | 4.17B |
| Book Value Per Share | 67.75 |
| Working Capital | 2.91B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.56 billion and capital expenditures -$45.05 million, giving a free cash flow of $1.51 billion.
| Operating Cash Flow | 1.56B |
| Capital Expenditures | -45.05M |
| Free Cash Flow | 1.51B |
| FCF Per Share | $25.01 |
Full Cash Flow StatementMargins
Gross margin is 92.15%, with operating and profit margins of 17.97% and 11.86%.
| Gross Margin | 92.15% |
| Operating Margin | 17.97% |
| Pretax Margin | 8.89% |
| Profit Margin | 11.86% |
| EBITDA Margin | 34.25% |
| EBIT Margin | 17.97% |
| FCF Margin | 37.23% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.26% |
| Shareholder Yield | 5.26% |
| Earnings Yield | 7.44% |
| FCF Yield | 23.36% |
Dividend DetailsAnalyst Forecast
The average price target for JAZZ is $183.08, which is 71.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $183.08 |
| Price Target Difference | 71.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 5.62% |
| EPS Growth Forecast (5Y) | 26.83% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.58 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.58 |
| Piotroski F-Score | 6 |